Clinical Trials Logo

Clinical Trial Summary

To improve the function and welfare of late stage solid cancer subjects by: - enabling subjects to benefit from a potentially promising drug under development - assessing initial evidence of improvement in Pain VAS score - assessing initial improvement in Performance Status (PS) - assessing initial improvement in oxygen saturation whenever it is feasible


Clinical Trial Description

To improve the function and welfare of late stage solid cancer subjects by: - enabling subjects to benefit from a potentially promising drug under development - assessing initial evidence of improvement in Pain VAS score - assessing initial improvement in Performance Status (PS) - assessing improvement in oxygen saturation whenever it is feasible/ dyspnea measurement (Modified Borg Scale) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03057314
Study type Interventional
Source Amorphical Ltd.
Contact
Status Terminated
Phase Phase 1
Start date June 25, 2017
Completion date December 31, 2019